相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term outcome of islet transplantation on insulin-dependent diabetes mellitus: An observational cohort study
Toshihiro Nakamura et al.
JOURNAL OF DIABETES INVESTIGATION (2020)
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation
Alberto Sanchez-Fueyo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Immunomodulation Followed by Antigen-Specific Treg Infusion Controls Islet Autoimmunity
Cecilia Cabello-Kindelan et al.
DIABETES (2020)
Regulatory T Cells and Human Disease
Shimon Sakaguchi et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Low-Dose Interleukin-2 Combined With Rapamycin Led to an Expansion of CD4+CD25+FOXP3+Regulatory T Cells and Prolonged Human Islet Allograft Survival in Humanized Mice
Min Hu et al.
DIABETES (2020)
Therapeutic Effects of BCG Vaccination on Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Yu-Chen Chang et al.
JOURNAL OF DIABETES RESEARCH (2020)
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
Birgit Sawitzki et al.
LANCET (2020)
Comparison of Pancreas vs. Islet Transplantation Outcomes from a Large Single Center
Braulio A. Marfil-Garza et al.
DIABETES (2020)
Regulatory T cells in solid organ transplantation
Muhammad Atif et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
T-reg cell-based therapies: challenges and perspectives
Caroline Raffin et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Methods to manufacture regulatory T cells for cell therapy
K. N. MacDonald et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
Michael J. Haller et al.
DIABETES (2019)
A new era of genetic engineering for autoimmune and inflammatory diseases
Dave Ewart et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Current state of organ transplant tolerance
Charles G. Rickert et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2019)
Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients
Elvira Jimenez Vera et al.
PLOS ONE (2019)
Next-generation regulatory T cell therapy
Leonardo M. R. Ferreira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study
Marie-Christine Vantyghem et al.
DIABETES CARE (2019)
Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases
Maryam Tahvildari et al.
JOURNAL OF IMMUNOLOGY (2019)
Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model
Daniel R. Holohan et al.
PLOS ONE (2019)
CRISPRa-mediated FOXP3 gene upregulation in mammalian cells
Vida Forstneric et al.
CELL AND BIOSCIENCE (2019)
Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7years from diagnosis
Ana Luisa Perdigoto et al.
DIABETOLOGIA (2019)
Effects of tacrolimus (FK506) and mycophenolate mofetil (MMF) on regulatory T cells and co-inhibitory receptors in the peripheral blood of human liver allograft patients
Qiang Zeng et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2019)
Preparation of Immunotolerant Space Under the Skin and Transplantation of Islets in the Space
Rei Kuwabara et al.
TISSUE ENGINEERING PART A (2019)
Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
Bart O. Roep et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
Marco Romano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes
Kevan C. Herold et al.
JCI INSIGHT (2019)
Regulatory T-cell Number in Peripheral Blood at 1 Year Posttransplant as Predictor of Long-term Kidney Graft Survival
David San Segundo et al.
TRANSPLANTATION DIRECT (2019)
mTOR Inhibition and Clinical Transplantation: Pancreas and Islet
Thierry Berney et al.
TRANSPLANTATION (2018)
Long-term Functioning of Allogeneic Islets in Subcutaneous Tissue Pretreated With a Novel Cyclic Peptide Without Immunosuppressive Medication
Rei Kuwabara et al.
TRANSPLANTATION (2018)
CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis
Fatemeh Safari et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2018)
Functional Interrogation of Primary Human T Cells via CRISPR Genetic Editing
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2018)
Regulatory T cells in autoimmune disease
Margarita Dominguez-Villar et al.
NATURE IMMUNOLOGY (2018)
Over ten-year insulin independence following single allogeneic islet transplant without T-cell depleting antibody induction
Jack Williams et al.
ISLETS (2018)
c-Jun N-terminal kinase 1 defective CD4+CD25+FoxP3+cells prolong islet allograft survival in diabetic mice
Deepak Tripathi et al.
SCIENTIFIC REPORTS (2018)
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants
James M. Mathew et al.
SCIENTIFIC REPORTS (2018)
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial
Sandrine Lablanche et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
Kayleigh M. van Megen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Gene Therapy with Regulatory T Cells: A Beneficial Alliance
Moanaro Biswas et al.
FRONTIERS IN IMMUNOLOGY (2018)
Foxp3+ T Regulatory Cells: Still Many Unanswered Questions-A Perspective After 20 Years of Study
Ethan M. Shevach
FRONTIERS IN IMMUNOLOGY (2018)
Emerging Functions of Regulatory T Cells in Tissue Homeostasis
Amit Sharma et al.
FRONTIERS IN IMMUNOLOGY (2018)
Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations
Willem M. Kuhtreiber et al.
NPJ VACCINES (2018)
The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review
Francisco Herrera-Gomez et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Treg cells-the next frontier of cell therapy Will regulatory T cells be a frontline therapy for autoimmunity and other diseases?
Jeffrey A. Bluestone et al.
SCIENCE (2018)
Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
Qunfang Zhang et al.
FRONTIERS IN IMMUNOLOGY (2018)
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes
Eleonora Seelig et al.
JCI INSIGHT (2018)
Treg-Centric View of Immunosuppressive Drugs in Transplantation: A Balancing Act
G. Camirand et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Clinical pancreatic islet transplantation
A. M. James Shapiro et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes
Long Shi et al.
GENE (2017)
Transplant trials with Tregs: perils and promises
Qizhi Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Autoreactive T cells in type 1 diabetes
Alberto Pugliese
JOURNAL OF CLINICAL INVESTIGATION (2017)
Peripheral blood regulatory T cell counts as a predictive biomarker for the outcome of kidney transplant: A systematic review
Francisco Herrera-Gomez et al.
MEDICINA CLINICA (2017)
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
Mohammad Alhadj Ali et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Treg therapy in transplantation: a general overview
Marco Romano et al.
TRANSPLANT INTERNATIONAL (2017)
Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections
Deborah Jane Holmes-Walker et al.
TRANSPLANTATION (2017)
Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells
Masahiro Okada et al.
EPIGENETICS & CHROMATIN (2017)
Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
Kelen C. R. Malmegrim et al.
FRONTIERS IN IMMUNOLOGY (2017)
Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision
Patrick R. Adair et al.
FRONTIERS IN IMMUNOLOGY (2017)
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression
Guido Sebastiani et al.
SCIENTIFIC REPORTS (2017)
T cells expressing chimeric antigen receptor promote immune tolerance
Antonio Pierini et al.
JCI INSIGHT (2017)
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants
S. Chandran et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
Caroline M. Hull et al.
DIABETOLOGIA (2017)
Cell-Based Therapies with T Regulatory Cells
Mateusz Gliwinski et al.
BIODRUGS (2017)
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy
Haiping Wang et al.
TRENDS IN CANCER (2017)
Regulatory T cells: tolerance induction in solid organ transplantation
T. Vaikunthanathan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Operational tolerance in kidney transplantation and associated biomarkers
A. Massart et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Can immunosuppression be stopped after liver transplantation?
Pierre-Alain Clavien et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States
D. C. Brennan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes
S. Moassesfar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Accessory cells for β-cell transplantation
W. Staels et al.
DIABETES OBESITY & METABOLISM (2016)
Phenotypical characterization of regulatory T cells in humans and rodents
A. L. Rodriguez-Perea et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Cytokine-based immune monitoring
O. Millan et al.
CLINICAL BIOCHEMISTRY (2016)
A Regulatory T-Cell Gene Signature Is a Specific and Sensitive Biomarker to Identify Children With New-Onset Type 1 Diabetes
Anne M. Pesenacker et al.
DIABETES (2016)
A Pilot Study of Operational Tolerance With a Regulatory T-cell-Based Cell Therapy in Living Donor Liver Transplantation
Satoru Todo et al.
HEPATOLOGY (2016)
Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?
Anabelle Visperas et al.
JOURNAL OF IMMUNOLOGY (2016)
Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway
Andrew B. Adams et al.
JOURNAL OF IMMUNOLOGY (2016)
The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients
Annick Massart et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Impact of Immune-Modulatory Drugs on Regulatory T Cell
Akiko Furukawa et al.
TRANSPLANTATION (2016)
Induced Regulatory T Cells: Their Development, Stability, and Applications
Mitsuhiro Kanamori et al.
TRENDS IN IMMUNOLOGY (2016)
Type 1 diabetes vaccine candidates promote human Foxp3+Treg induction in humanized mice
Isabelle Serr et al.
NATURE COMMUNICATIONS (2016)
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
John A. Todd et al.
PLOS MEDICINE (2016)
Treg activation defect in type 1 diabetes: correction with TNFR2 agonism
Yoshiaki Okubo et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes
Howard R. Seay et al.
JCI INSIGHT (2016)
Alginate Encapsulant Incorporating CXCL12 Supports Long-Term Allo- and Xenoislet Transplantation Without Systemic Immune Suppression
T. Chen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
Saskia J. A. M. Santegoets et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Immunological Shielding by Induced Recruitment of Regulatory T-Lymphocytes Delays Rejection of Islets Transplanted in Muscle
Evelina Vagesjo et al.
CELL TRANSPLANTATION (2015)
Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance
Hanyu Zeng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial
Genies Treiber et al.
CLINICAL IMMUNOLOGY (2015)
Tolerance signatures in transplant recipients
Kenneth A. Newell et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2015)
Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes The Pre-POINT Randomized Clinical Trial
Ezio Bonifacio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
Michelle Rosenzwajg et al.
JOURNAL OF AUTOIMMUNITY (2015)
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
Mark R. Rigby et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans
Makoto Miyara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The need for minimization strategies: current problems of immunosuppression
Jamal Bamoulid et al.
TRANSPLANT INTERNATIONAL (2015)
Coaggregates of Regulatory T Cells and Islet Cells Allow Long-term Graft Survival in Liver Without Immunosuppression
Naohiro Takemoto et al.
TRANSPLANTATION (2015)
Regulatory T cells: serious contenders in the promise for immunological tolerance in transplantation
Niloufar Safinia et al.
FRONTIERS IN IMMUNOLOGY (2015)
Attenuation of Donor-Reactive T Cells Allows Effective Control of Allograft Rejection Using Regulatory T Cell Therapy
K. Lee et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Therapy of type 1 diabetes with CD4+CD25high CD127-regulatory T cells prolongs survival of pancreatic islets - Results of one year follow-up
Natalia Marek-Trzonkowska et al.
CLINICAL IMMUNOLOGY (2014)
Islet cell transplant and the incorporation of Tregs
Adam Krzystyniak et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2014)
B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
Mark D. Pescovitz et al.
DIABETES CARE (2014)
Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
Tihamer Orban et al.
DIABETES CARE (2014)
Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
Ronnie Aronson et al.
DIABETES CARE (2014)
Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study
P. Ambery et al.
DIABETIC MEDICINE (2014)
Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro
Evis Havari et al.
IMMUNOLOGY (2014)
IL-7 receptor blockade following T cell depletion promotes long-term allograft survival
Hoa-Le Mai et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
Sofia V. Abrahamsson et al.
BRAIN (2013)
Homeostatic T Cell Proliferation after Islet Transplantation
Paolo Monti et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
Lorenzo Piemonti et al.
DIABETES (2013)
Evidence for Rapamycin Toxicity in Pancreatic beta-Cells and a Review of the Underlying Molecular Mechanisms
Adam D. Barlow et al.
DIABETES (2013)
Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
Kevan C. Herold et al.
DIABETES (2013)
Prospective Multicenter Clinical Trial of Immunosuppressive Drug Withdrawal in Stable Adult Liver Transplant Recipients
Carlos Benitez et al.
HEPATOLOGY (2013)
The Ubiquitin Ligase Stub1 Negatively Modulates Regulatory T Cell Suppressive Activity by Promoting Degradation of the Transcription Factor Foxp3
Zuojia Chen et al.
IMMUNITY (2013)
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Antoinette Moran et al.
LANCET (2013)
Novel Sphingosine-1-Phosphate Receptor Modulator KRP203 Combined With Locally Delivered Regulatory T Cells Induces Permanent Acceptance of Pancreatic Islet Allografts
Mithun Khattar et al.
TRANSPLANTATION (2013)
Foxp3+ Regulatory T Cells in Mouse Models of Type 1 Diabetes
Cathleen Petzold et al.
JOURNAL OF DIABETES RESEARCH (2013)
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
Mark R. Rigby et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Agnes Hartemann et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
Stephen E. Gitelman et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Natural and induced T regulatory cells in cancer
Dennis O. Adeegbe et al.
FRONTIERS IN IMMUNOLOGY (2013)
Potent Induction Immunotherapy Promotes Long-Term Insulin Independence After Islet Transplantation in Type 1 Diabetes
M. D. Bellin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Induction of Allograft Tolerance by Monoclonal CD3 Antibodies: A Matter of Timing
S. You et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Lymphodepletion and Homeostatic Proliferation: Implications for Transplantation
N. K. Tchao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
The battle against immunopathology: infectious tolerance mediated by regulatory T cells
David M. Gravano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
FoxP3+, and not CD25+, T cells increase post-transplant in islet allotransplant recipients following anti-CD25+rATG immunotherapy
Kelly Hire et al.
CELLULAR IMMUNOLOGY (2012)
Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes
Michelle Rosenzwajg et al.
CURRENT DIABETES REPORTS (2012)
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs Yet Transiently Impairs β-cell Function
S. Alice Long et al.
DIABETES (2012)
Administration of CD4+CD25highCD127- Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children
Natalia Marek-Trzonkowska et al.
DIABETES CARE (2012)
Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010
Franca B. Barton et al.
DIABETES CARE (2012)
Suppression assays with human T regulatory cells: A technical guide
Alicia N. McMurchy et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
IL-7 Abrogates Suppressive Activity of Human CD4+CD25+ FOXP3+ Regulatory T Cells and Allows Expansion of Alloreactive and Autoreactive T Cells
Anne-Kristin Heninger et al.
JOURNAL OF IMMUNOLOGY (2012)
Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes
Denise L. Faustman et al.
PLOS ONE (2012)
Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation
Pervinder Sagoo et al.
FRONTIERS IN IMMUNOLOGY (2012)
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity
Federica Barzaghi et al.
FRONTIERS IN IMMUNOLOGY (2012)
Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly
Anandharaman Veerapathran et al.
BLOOD (2011)
Do CD4(+)Foxp3(+) Treg cells correlate with transplant outcomes: A systematic review on recipients of solid organ transplantation
Juan Shan et al.
CELLULAR IMMUNOLOGY (2011)
Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes
Alessandra Ferraro et al.
DIABETES (2011)
An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4+ T cells
S. A. Long et al.
GENES AND IMMUNITY (2011)
A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes
Laura Espino-Paisan et al.
IMMUNOGENETICS (2011)
Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets
Joel Montane et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Anti-CD3 Therapy Promotes Tolerance by Selectively Depleting Pathogenic Cells while Preserving Regulatory T Cells
Cristina Penaranda et al.
JOURNAL OF IMMUNOLOGY (2011)
Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
Stephanie A. McClymont et al.
JOURNAL OF IMMUNOLOGY (2011)
Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial
Nicole Sherry et al.
LANCET (2011)
Reduced Progression of Diabetic Microvascular Complications With Islet Cell Transplantation Compared With Intensive Medical Therapy
David M. Thompson et al.
TRANSPLANTATION (2011)
A Genome-Wide Meta-Analysis of Six Type 1 Diabetes Cohorts Identifies Multiple Associated Loci
Jonathan P. Bradfield et al.
PLOS GENETICS (2011)
Experience with a Novel Efalizumab-Based Immunosuppressive Regimen to Facilitate Single Donor Islet Cell Transplantation
N. A. Turgeon et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance
Dusan Hanidziar et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2010)
Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant
Nicola Gagliani et al.
DIABETES (2010)
No Effect of the 1α,25-Dihydroxyvitamin D3 on β-Cell Residual Function and Insulin Requirement in Adults With New-Onset Type 1 Diabetes
Markus Walter et al.
DIABETES CARE (2010)
Failure to Preserve β-Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New-Onset Type 1 Diabetes
Peter A. Gottlieb et al.
DIABETES CARE (2010)
Immunological aspects of pancreatic islet cell transplantation
Jamil Azzi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
Thomas R. Malek et al.
IMMUNITY (2010)
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
Yenkel Grinberg-Bleyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response
Zhigang Fan et al.
NATURE MEDICINE (2010)
Mechanism of cellular rejection in transplantation
Elizabeth Ingulli
PEDIATRIC NEPHROLOGY (2010)
Islet Transplantation in Type 1 Diabetic Patients Using Calcineurin Inhibitor-Free Immunosuppressive Protocols Based on T-Cell Adhesion or Costimulation Blockade
Andrew M. Posselt et al.
TRANSPLANTATION (2010)
Regulatory T-Cell Counter-Regulation by Innate Immunity Is a Barrier to Transplantation Tolerance
J. I. Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Long-Term Insulin-Independence After Allogeneic Islet Transplantation for Type 1 Diabetes: Over the 10-Year Mark
T. Berney et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study
S. L. Thrower et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Analysis of islet inflammation in human type 1 diabetes
A. Willcox et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Etanercept Treatment in Children With New-Onset Type 1 Diabetes Pilot randomized, placebo-controlled, double-blind study
Lucy Mastrandrea et al.
DIABETES CARE (2009)
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Makoto Miyara et al.
IMMUNITY (2009)
Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells
Helene Bour-Jordan et al.
IMMUNOLOGICAL REVIEWS (2009)
In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression
Kylie E. Webster et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation
Christian Toso et al.
TRANSPLANT INTERNATIONAL (2009)
Conversion From Calcineurin Inhibitor to Mycophenolate Mofetil-Based Immunosuppression Changes the Frequency and Phenotype of CD4+FOXP3+ Regulatory T Cells
Ahmet Demirkiran et al.
TRANSPLANTATION (2009)
Differential Effect of Cyclosporine and Mycophenolic Acid on the Human Regulatory T Cells and TH-17 Cells Balance
F. Abadja et al.
TRANSPLANTATION PROCEEDINGS (2009)
Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes
M. D. Bellin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation
J. A. Bluestone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-Cells
Paolo Monti et al.
DIABETES (2008)
Presence of FoxP3+ regulatory T cells predicts outcome of subclinical rejection of renal allografts
Oriol Bestard et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation
Volkert A. L. Huurman et al.
PLOS ONE (2008)
FoxP3 in Peripheral Blood Is Associated With Operational Tolerance in Liver Transplant Patients During Immunosuppression Withdrawal
Jose A. Pons et al.
TRANSPLANTATION (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury
Piero Ruggenenti et al.
TRANSPLANTATION (2007)
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance
Sophie Brouard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: Role of ursodeoxycholic acid
Nimer Assy et al.
TRANSPLANTATION (2007)
No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes
Todd Brusko et al.
DIABETES (2007)
At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+high T-Cell Fraction
Sanja Glisic-Milosavljevic et al.
PLOS ONE (2007)
CD4+ CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients
J. H. L. Velthuis et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
The effects of calcitriol and nicotinamide on residual pancreatic β-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI)
D. Pitocco et al.
DIABETIC MEDICINE (2006)
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence
G Tisone et al.
JOURNAL OF HEPATOLOGY (2006)
Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance
S Louis et al.
TRANSPLANTATION (2006)
Long-term outcome of immunosuppression withdrawal after liver transplantation
R Girlanda et al.
TRANSPLANTATION PROCEEDINGS (2005)
The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation
P Tryphonopoulos et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody
BJ Hering et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes
QZ Tang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Autoreactive T cells in healthy individuals
NA Danke et al.
JOURNAL OF IMMUNOLOGY (2004)
Cutting edge:: CD28 controls peripheral homeostasis of CD4+CD25+
QZ Tang et al.
JOURNAL OF IMMUNOLOGY (2003)
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation
EK Waller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression
JA Pons et al.
TRANSPLANTATION (2003)
Autoantibody response to islet transplantation in type 1 diabetes
E Bosi et al.
DIABETES (2001)
Weaning of immunosuppression in living donor liver transplant recipients
M Takatsuki et al.
TRANSPLANTATION (2001)
Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance
S Gregori et al.
JOURNAL OF IMMUNOLOGY (2001)
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
AMJ Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes
S Braghi et al.
DIABETES (2000)
分享论文
